Related Experiment Video
Updated: Feb 16, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Cycloartobiloxanthone Induces Human Lung Cancer Cell Apoptosis via Mitochondria-dependent Apoptotic Pathway
Nattanan Losuwannarak1,2, Boonchoo Sritularak3, Pithi Chanvorachote4,2
1Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Background:
Lung cancer is one of most malignant types of cancer and new anticancer agents are still required. Cycloartobiloxanthone, a flavonoid isolated from stem bark of Artocarpus gomezianus, has potential for being developed for anticancer therapy.
Materials And Methods:
Cytotoxicity of cycloartobiloxanthone was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) assay against four human lung cancer cell lines (H23, H460, H292 and A549) and their half-maximal inhibitory concentrations (IC50) were assessed. Apoptotic induction in H460 cells was investigated by Hoechst 33342/propidium iodide (PI) staining assay and protein hallmarks of mitochondria-dependent apoptotic pathway were examined by western blot analysis.
Results:
Cycloartobiloxanthone exhibited potent cytotoxic effect on both small and non-small cell lung cancer cells. Nuclear Hoechst/PI staining revealed that apoptotic cell death was the main mechanism of toxicity of cycloartobiloxanthone. The apoptosis-inducing potency of cycloartobiloxanthone was comparable to those of standard anticancer drugs cisplatin and etoposide at the same concentration. Protein analysis further showed that apoptosis was mediated via mitochondria-dependent pathway. p53 was activated in cells treated with cycloartobiloxanthone. Subsequently, pro-apoptotic protein B-cell lymphoma 2 (BCL2)-associated X protein (BAX) was found to be significantly increased, concomitantly with the decrease of anti-apoptotic proteins BCL2 and myeloid cell leukemia 1 (MCL1). Moreover, markers of the intrinsic apoptosis pathway, namely activated caspase-9, activated caspase-3, and cleaved poly(ADP-ribose)polymerase (PARP), dramatically increased in cycloartobiloxanthone-treated cells compared to the non-treated controls.
Conclusion:
Cycloartobiloxanthone has anticancer activity against human lung cancer cells by triggering mitochondrial apoptotic caspase-dependent mechanism. This compound might have promising effects for cancer therapy.
Insights
Cycloartobiloxanthone, a natural compound, effectively kills lung cancer cells by inducing apoptosis through a mitochondria-dependent pathway. This flavonoid shows promise as a novel anticancer therapeutic agent.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Lung cancer remains a significant global health challenge, necessitating the development of novel therapeutic agents.
- Cycloartobiloxanthone, a flavonoid derived from Artocarpus gomezianus, presents potential as an anticancer drug.
Purpose of the Study:
- To evaluate the anticancer activity of cycloartobiloxanthone against human lung cancer cell lines.
- To elucidate the mechanism of action, specifically focusing on apoptosis induction and the involvement of the mitochondrial pathway.
Main Methods:
- Cytotoxicity was assessed using the MTT assay on lung cancer cell lines (H23, H460, H292, A549).
- Apoptosis was analyzed via Hoechst 33342/propidium iodide staining.
- Western blot analysis was employed to examine key proteins in the mitochondria-dependent apoptotic pathway.
Main Results:
- Cycloartobiloxanthone demonstrated potent cytotoxic effects on both small and non-small cell lung cancer.
- Apoptotic cell death was confirmed as the primary mechanism, comparable to cisplatin and etoposide.
- The compound activated p53, upregulated pro-apoptotic BAX, downregulated anti-apoptotic BCL2 and MCL1, and increased cleaved caspase-9, caspase-3, and PARP, indicating activation of the intrinsic apoptotic pathway.
Conclusions:
- Cycloartobiloxanthone exhibits significant anticancer activity against human lung cancer cells.
- The mechanism involves the induction of mitochondrial apoptotic, caspase-dependent pathways.
- This compound holds promise for future cancer therapy development.
More Related Videos
11:21Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
Published on: January 26, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
cAMP-dependent Protein Kinase Pathways
Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...